GlobalData plc

05/16/2022 | Press release | Distributed by Public on 05/16/2022 06:02

Uptake of Adtralza, Rinvoq and Cibinqo for treating atopic dermatitis will be slow in the UK following NICE’s rejection, says GlobalData